DNA synthesizer market to reach USD 754.55M by 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global DNA synthesizer market size, share & trends analysis report by type (benchtop DNA synthesizers and large-scale DNA synthesizers), application (Drug discovery & development, genetic engineering, and clinical diagnostics) and end users (Academic & research institutes, pharmaceutical & biotechnology companies and clinical laboratories.), region, market outlook and industry analysis 2031”

According to the latest research by InsightAce Analytic, the global DNA Synthesizer market size is estimated to reach over USD 754.55 million by 2031, exhibiting a CAGR of 14.8% during the forecast period.

DNA synthesis refers to the chemical process of producing sequences, which are comparatively brief fragments of nucleic acids. As it enables rapid and cost-effective access to custom-made oligonucleotides of the essential sequence, the method is helpful and practical in contemporary laboratory practice.

One of the key drivers is the rising research and development activities related to gene synthesis. Researchers are constantly exploring new avenues in genetics and genomics, and DNA synthesis plays a crucial role in enabling these advancements. Technological improvements in molecular separation and protein purification have also contributed to the market’s growth.

These advancements help develop more reliable, efficient, and cost-effective solutions for DNA synthesis. As the processes become faster and more affordable, it becomes easier for researchers and industries to utilize DNA synthesis in their work. Additionally, the expanding applications of DNA synthesis across multiple sectors further fuel market expansion. In medicine, DNA synthesis is used in diagnostic and therapeutic applications. It enables the development of personalized medicine, targeted therapies, and genetic testing. Academic and industrial research also heavily rely on DNA synthesis to study various biological processes and develop new technologies.

Moreover, DNA synthesis finds applications in synthetic biology, immunology, cancer research, food science, antibody development, agriculture, and more. The wide range of sectors utilizing DNA synthesis indicates its growing importance and demand across diverse industries.

As a result of these factors, the need for DNA synthesis is expected to increase rapidly over the forecast period. The market’s growth prospects remain promising, driven by ongoing research and development efforts, technological advancements, and the expanding applications of DNA synthesis in various fields.

Some of the prominent players in the DNA synthesizer market are:

• Danaher Corporation
• Twist Bioscience
• Kilobaser
• LGC Limited
• CSBio
• K&A Labs GmBH
• DNA Script
• Oligomer Apes
• PolyGene AG
• Biolytic Lab Performance, Inc.

Market dynamics:
Drivers:
The growing demand for efficient DNA synthesizers in life science laboratories, pharmaceutical companies, and biotechnology firms drives the market. This increasing demand is a significant factor contributing to market growth. Additionally, advancements in genomics and life sciences, along with the rising importance of DNA synthesizers in synthetic and molecular biology, further support the expansion of the market.

The rising demand for novel synthesis technologies and continuous technological advancements also propels the global market. These factors drive innovation and provide new opportunities for market participants. Furthermore, improvements in nucleic acid synthesis methods have opened new avenues for the market, enabling the development of more reliable and efficient DNA synthesizers.

Challenges:
The high cost of equipment and reagents might be a hurdle for university institutions and smaller research labs with tighter resources. The cost-effectiveness and accessibility of DNA synthesizers continue to be obstacles to their widespread use. Continuous difficulties include raising synthesizer throughput to support larger-scale synthesis programs and raising synthesis process effectiveness. Addressing these throughput and efficiency issues is essential because researchers frequently need huge amounts of produced DNA in a short amount of time. Due to a lack of understanding or familiarity with the technology, certain institutions and researchers may be reluctant to use DNA synthesizers, which limits the market’s potential growth.

Regional trends:
The North American, DNA synthesizer market is expected to register a major market share. Due to large enterprises and government activities supporting the creation and implementation of synthetic biology programs, North America represented the most impressive revenue share. The increased use of techniques linked to gene editing and synthesis by drug and diagnostic makers in the United States has encouraged the expansion of the local market. Besides, Europe had a substantial share of the market.

The region’s marketing of synthetic gene products and regulatory approval of those items have also aided market expansion. Several cellular and gene therapies have recently received regional approval, which promotes more investment in this area by other enterprises. The problem is brought on by multiregional businesses investing more in the local market. InsightAce Analytic